0001022079-18-000008.txt : 20180126
0001022079-18-000008.hdr.sgml : 20180126
20180126164307
ACCESSION NUMBER: 0001022079-18-000008
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180124
FILED AS OF DATE: 20180126
DATE AS OF CHANGE: 20180126
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Doherty Catherine T.
CENTRAL INDEX KEY: 0001520897
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12215
FILM NUMBER: 18552454
MAIL ADDRESS:
STREET 1: C/O QUEST DIAGNOSTICS
STREET 2: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC
CENTRAL INDEX KEY: 0001022079
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 161387862
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
BUSINESS PHONE: 9735202700
MAIL ADDRESS:
STREET 1: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
FORMER COMPANY:
FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC
DATE OF NAME CHANGE: 19960903
4
1
wf-form4_151700297271754.xml
FORM 4
X0306
4
2018-01-24
0
0001022079
QUEST DIAGNOSTICS INC
DGX
0001520897
Doherty Catherine T.
500 PLAZA DRIVE
SECAUCUS
NJ
07094
0
1
0
0
SVP, Group Exec. Clin. Fran.
Common Stock
2018-01-24
4
M
0
21294
52.165
A
90709
D
Common Stock
2018-01-24
4
S
0
21294
104
D
69415
D
Common Stock
3834
I
401(k)/SDCP
Stock Options (Right to Buy)
52.165
2018-01-24
4
M
0
21294
52.165
D
2024-02-13
Common Stock
21294.0
0
D
This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 27, 2017.
These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
The options vested in three equal annual installments beginning with the first on February 13, 2015, the second on February 13, 2016 and the final on February 13, 2017.
/s/ Elena H. Radine, Attorney in Fact for Catherine T. Doherty
2018-01-26